MRI dye study reveals signal changes in brain disease patients
NCT ID NCT04906941
First seen Jan 06, 2026 · Last updated May 21, 2026 · Updated 19 times
Summary
This study looked at how a contrast dye called gadolinium changes the QSM signal on MRI scans in people with white matter disease. 73 participants had an MRI without dye, then with dye (as part of their normal care), and then another without dye. The goal was to measure the difference in the QSM signal before and after the dye injection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WHITE MATTER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hhopital fondation adolphe de rothschild
Paris, Paris, 75019, France
Conditions
Explore the condition pages connected to this study.